Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,26 USD | -2,11% | -4,70% | +38,22% |
18/03 | Fulcrum Therapeutics benoemt Patrick Horn tot medisch directeur | MT |
18/03 | Fulcrum Therapeutics, Inc. Kondigt wijzigingen in de leiding aan | CI |
Omzet 2024 * | 1,68 mln. 1,55 mln. | Omzet 2025 * | 11,67 mln. 10,8 mln. | Marktkapitalisatie | 586 mln. 542 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -113 mln. -105 mln. | Nettowinst (verlies) 2025 * | -117 mln. -108 mln. | EV/omzet 2024 * | 314 x |
Nettoliquiditeiten 2024 * | 58,66 mln. 54,28 mln. | Nettoschuld 2025 * | 119 mln. 110 mln. | EV/omzet 2025 * | 60,4 x |
K/w-verhouding 2024 * |
-5,5
x | K/w-verhouding 2025 * |
-5,75
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,62% |
Recentste transcriptie over Fulcrum Therapeutics, Inc.
1 dag | -1,80% | ||
1 week | -4,70% | ||
Lopende maand | -8,62% | ||
1 maand | -9,59% | ||
3 maanden | +36,01% | ||
6 maanden | +108,72% | ||
Lopend jaar | +38,22% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alex Sapir
CEO | Chief Executive Officer | 57 | 01-07-23 |
Alan Musso
DFI | Director of Finance/CFO | 61 | 07-08-23 |
Chief Tech/Sci/R&D Officer | - | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Geraghty
BRD | Director/Board Member | 70 | 19-07-16 |
Director/Board Member | 70 | 01-12-16 | |
James Collins
BRD | Director/Board Member | 58 | 01-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.03% | 0 M€ | 0,00% | - | |
0.02% | 2 M€ | -.--% | ||
0.00% | 8 M€ | +9,29% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 9,34 | -1,27% | 17 451 |
27-03-24 | 9,46 | +3,61% | 464 287 |
26-03-24 | 9,13 | -3,18% | 742 178 |
25-03-24 | 9,43 | -2,48% | 846 881 |
22-03-24 | 9,67 | -1,23% | 1 215 641 |
uitgestelde koers Nasdaq, 28 maart 2024 om 15:11 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,22% | 586 mln. | |
+8,80% | 45,97 mld. | |
+52,56% | 43,93 mld. | |
+9,85% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+17,26% | 27,18 mld. | |
-20,27% | 19,44 mld. | |
+14,08% | 13,83 mld. | |
+31,67% | 12,4 mld. | |
+8,54% | 11,45 mld. |